Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Mesa Laboratories, Inc. - Common Stock (NQ:MLAB)

60.49 -3.80 (-5.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mesa Laboratories, Inc. - Common Stock

< Previous 1 2 3 Next >
Mesa Laboratories's Return on Invested Capital Insights
According to Benzinga Pro data, during Q1, Mesa Laboratories (NASDAQ:MLAB) posted sales of $50.45 million. Earnings were up 19.39%, but Mesa Laboratories still reported an overall loss of $1.44... 
Via Benzinga
Mesa Laboratories: Q1 Earnings Insights
  Mesa Laboratories (NASDAQ:MLAB) reported its Q1 earnings results on Thursday, August 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Mesa Laboratories: Q4 Earnings Insights
Mesa Laboratories (NASDAQ:MLAB) reported its Q4 earnings results on Tuesday, May 31, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Mesa Laboratories: Q3 Earnings Insights
  Mesa Laboratories (NASDAQ:MLAB) reported its Q3 earnings results on Thursday, February 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
How Good Are Mesa Laboratories's Earnings? | Return On Invested Capital
According to Benzinga Pro, during Q2, Mesa Laboratories (NASDAQ:MLAB) earned $4.20 million, a 34.52% increase from the preceding quarter. Mesa Laboratories also posted a total of... 
Via Benzinga
Mesa Labs Scoops Up Molecular Diagnostics Tools Firm For $300M
Mesa Laboratories Inc (NASDAQ: MLAB) has agreed to acquire Agena Bioscience Inc for a cash purchase price of $300 million. The San Diego, California-based... 
Via Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Looking Into Mesa Laboratories's Return On Capital Employed
According to Benzinga Pro, during Q1, Mesa Laboratories (NASDAQ:MLAB) earned $3.12 million, a 27.3% increase from the preceding quarter. Mesa Laboratories's sales decreased to $34... 
Via Benzinga
Looking Into Mesa Laboratories's Return On Capital Employed
Looking at Q4, Mesa Laboratories (NASDAQ:MLAB) earned $4.30 million, a 19427.27% increase from the preceding quarter. Mesa Laboratories also posted a total of $37.96 million in... 
Via Benzinga
Mesa Laboratories: Q4 Earnings Insights
Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98,... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.